Comment: low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial.
Rowell
Crescent E
CE
Amarshi
Naseem
N
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D031204:Caloric Restriction; D004311:Double-Blind Method; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D000077403:Orlistat; D050177:Overweight / Q000187:drug effects*; D012107:Research Design
D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat